Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.

Saved in:
Bibliographic Details
Title: Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.
Authors: Krishnamoorthy S; Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641 021, India., Sabanayagam R; Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641 021, India., Periyasamy L; Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641 021, India., Muruganantham B; Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641 021, India., Muthusami S; Department of Biochemistry, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641 021, India. sridharuniv@gmail.com.; Centre for Cancer Research, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641 021, India. sridharuniv@gmail.com.
Source: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Mar 23; Vol. 41 (4), pp. 89. Date of Electronic Publication: 2024 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first